Update on the Gastrointestinal Microbiome in Systemic Sclerosis.

Area of Science:

• Gastroenterology
• Immunology
• Microbiome Research

Background:

• The gut microbiota plays a crucial role in immune system development and function.
• Aberrations in gut microbial composition are increasingly implicated in the pathogenesis of autoimmune diseases.
• Systemic sclerosis (SSc) is an autoimmune disease where gastrointestinal involvement is common.

Purpose of the Study:

• To review and synthesize recent findings on gastrointestinal microbiota alterations in patients with systemic sclerosis (SSc).
• To understand the relationship between gut dysbiosis and SSc pathogenesis, symptoms, and clinical outcomes.

Main Methods:

• Literature review of studies investigating gut microbiota in systemic sclerosis.
• Analysis of microbial composition changes, including abundance of specific genera.
• Correlation of microbial findings with gastrointestinal symptoms and disease severity.

Main Results:

• Patients with SSc exhibit decreased abundance of beneficial commensal bacteria (e.g., Faecalibacterium, Clostridium, Bacteroides).
• Increased abundance of pathobiont genera (e.g., Fusobacterium, Prevotella, Erwinia) is observed in SSc patients.
• Specific microbial genera have been linked to the severity of gastrointestinal symptoms in SSc.

Conclusions:

• Gut microbiota perturbations are common in systemic sclerosis and may contribute to inflammation, fibrosis, and disease progression.
• Further research is needed to elucidate the precise mechanisms by which microbiota affect SSc.
• Interventional strategies targeting gut microbiota (e.g., diet, probiotics, fecal transplantation) hold potential for improving SSc patient outcomes.